SureTrader
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

I don’t think Phase 3 can be skipped,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
LilKahuna Member Profile
Member Level 
Followed By 247
Posts 19,823
Boards Moderated 1
Alias Born 10/03/04
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/22/2017 6:02:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/11/2017 12:47:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2017 6:04:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/11/2017 6:04:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:27:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:24:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/8/2017 4:18:08 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:33 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:16:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2017 4:04:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2017 4:19:05 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2017 4:09:09 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/28/2017 12:50:45 PM
Bahamas Development Corp. (OTC Pink: BDCI) $2.4 Million in Sales and 10% Quarterly Growth – Issues Guidance InvestorsHub NewsWire - 4/17/2017 7:03:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/31/2017 4:25:24 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/29/2017 4:13:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2017 11:29:27 AM
LilKahuna Member Level  Friday, 10/06/17 10:20:24 AM
Re: DesireToLearn post# 199223
Post # of 218030 
I don’t think Phase 3 can be skipped, though I hope the same. But, I do think B-OM will be licensed independently of the B platform since it is an oral rinse. That can easily come in the next quarter or two and for a very large upfront payment.

Dr. Scholls introduces new sexy lacy insoles.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist